13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001214659-24-014472
Total Value
$959.5M
Positions
32
Other Managers
0
Confidential Omitted
No
Holdings (32)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY, INC. | CGON | 3,670,206 | $115.9M | 12.08% |
| 2 | DYNE THERAPEUTICS, INC | DYN | 2,650,150 | $93.5M | 9.75% |
| 3 | Abivax SA | AAVXF | 6,056,596 | $80.1M | 8.34% |
| 4 | SILENCE THERAPEUTICS PLC | SLNCF | 3,295,350 | $62.6M | 6.53% |
| 5 | COGENT BIOSCIENCES INC | COGT | 6,964,375 | $58.7M | 6.12% |
| 6 | SAVARA INC. | SVRA | 12,362,205 | $49.8M | 5.19% |
| 7 | MADRIGAL PHARMACEUTICALS INC | MDGL | 149,283 | $41.8M | 4.36% |
| 8 | EDGEWISE THERAPEUTICS, INC. | EWTX | 2,272,728 | $40.9M | 4.27% |
| 9 | KEROS THERAPEUTICS, INC. | KROS | 879,344 | $40.2M | 4.19% |
| 10 | MINERALYS THERAPEUTICS, INC. | MLYS | 3,185,185 | $37.3M | 3.88% |
| 11 | OCULAR THERAPEUTIX, INC. | OCUL | 5,319,148 | $36.4M | 3.79% |
| 12 | TYRA BIOSCIENCES INC | TYRA | 1,989,103 | $31.8M | 3.31% |
| 13 | KURA ONCOLOGY INC | KURA | 1,423,642 | $29.3M | 3.06% |
| 14 | STRUCTURE THERAPEUTICS INC | GPCR | 694,547 | $27.3M | 2.84% |
| 15 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,890,816 | $26.1M | 2.72% |
| 16 | ASTRIA THERAPEUTICS, INC. | 04635X102 | 2,761,861 | $25.1M | 2.62% |
| 17 | COMPASS PATHWAYS PLC | CMPS | 3,858,000 | $23.3M | 2.43% |
| 18 | SOLENO THERAPEUTIVS, INC. | 834203200 | 550,000 | $22.4M | 2.34% |
| 19 | Disc Medicine, Inc. | IRON | 486,957 | $21.9M | 2.29% |
| 20 | TOURMALINE BIO INC | 89157D105 | 1,477,593 | $19.0M | 1.98% |
| 21 | TARSUS PHARMACEUTICALS, INC. | TARS | 556,317 | $15.1M | 1.58% |
| 22 | ADVERUM BIOTECHNOLOGIES, INC. | 00773U108 | 2,008,340 | $13.8M | 1.44% |
| 23 | VISTAGEN THERAPEUTICS INC | VTGN | 2,676,580 | $9.3M | 0.97% |
| 24 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $8.3M | 0.87% |
| 25 | EyePoint Pharmaceuticals, Inc. | EYPT | 922,335 | $8.0M | 0.84% |
| 26 | C4 THERAPEUTICS, INC. | CCCC | 1,276,574 | $5.9M | 0.61% |
| 27 | NEKTAR THERAPEUTICS | NKTR | 4,000,000 | $5.0M | 0.52% |
| 28 | AEROVATE THERAPEUTICS INC | 008064107 | 2,240,809 | $3.7M | 0.39% |
| 29 | AN2 Therapeutics, Inc. | ANTX | 1,555,118 | $3.3M | 0.35% |
| 30 | KODIAK SCIENCES INC | KOD | 899,999 | $2.1M | 0.22% |
| 31 | VENTYX BIOSCIENCES, INC | 92332V107 | 316,195 | $730,410 | 0.08% |
| 32 | CABALETTA BIO, INC | CABA | 86,795 | $649,227 | 0.07% |